Ilant Health, an obesity care company for employers and health plans, announced Tuesday that it secured $15 million in Series A funding. New York City-based Ilant Health is a value-based
What Data Delays Are Costing Healthcare — And Its Patients
Healthcare organizations use data to guide care, manage benefits and understand how members use services. Yet most of healthcare still works with information that arrives too late to be useful.
Massachusetts Attorney General Sues UnitedHealthcare, Alleges $100M MassHealth Fraud
Massachusetts Attorney General Andrea Joy Campbell sued UnitedHealthcare on Friday, alleging the insurer “falsely manipulated” the health status of MassHealth members enrolled in the Senior Care Options plan in order
Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics
Servier is expanding its scope in neurology to include neuromuscular disorders by acquiring a clinical-stage Edgewise Therapeutics drug that offers a novel approach to treating two rare neuromuscular disorders. Per
Are We Measuring Metabolic Health All Wrong?
Modern medicine has made remarkable advances in treating metabolic disease. We have more effective medications, better clinical guidelines, and a deeper understanding of the interplay between obesity, diabetes, cardiovascular disease,
Why Ob-Gyns, States, and Plans, Should Care About Oral Health
Even though teeth are very much part of the human body, dental care has long stood apart from healthcare. That’s presumably because taking care of teeth may have more of
Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
Continuous glucose monitoring is continuing to expand beyond its traditional role in diabetes care. On Wednesday, Silicon Valley-based startup Signos raised $20 million for its glucose monitoring platform for weight
4 Notable Health Tech Funding Announcements in May
Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several
AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer
AbbVie’s strategy of growing in oncology by focusing on a particular type of targeted therapy is paying off with another FDA approval, this time for a drug developed for an
Aging is Soon to Be a Preventable Disease
Medicine has always framed its highest obligation as responding to suffering. But the greatest failure of modern healthcare may not be how we treat disease, it is how confidently we









